Soleno Therapeutics, Inc. · NASDAQ:SLNO
Adage Capital Management, L.P.'s stake in Soleno Therapeutics, Inc. fell to 2.64% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Adage Capital Management, L.P.'s stake in Soleno Therapeutics, Inc. fell to 2.64%, 1,401,576 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 2.64%
- Shares
- 1,401,576
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 2.64% | 1,401,576 |
| Robert Atchinson | 2.64% | 1,401,576 |
| Phillip Gross | 2.64% | 1,401,576 |
Source
Related
- Soleno Therapeutics, Inc.
- Adage Capital Management, L.P.
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13G/A · Adage Capital Management, L.P. · May 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026